Custom Search
Monday, January 11, 2010
New Therapy Grants Program From The Epilepsy Research Foundation
The New Therapy Grants Program seeks to advance the development of specific new therapies including new medicines and therapeutic devices. Consistent with the theme of translational research, all grant proposals must demonstrate a clear path from the lab to the patient. Other areas of consideration include but are not limited to:
* Seed funding for preliminary and targeted work deemed necessary to explore novel therapeutic approaches
* Projects which if successful offer a clear path to downstream development
* Proposals that support the commercialization of exceptional academic research projects
* Research to bring new approaches and therapy to children
Key issues for reviewers are whether the program could lead to a new therapy that is approvable by FDA or meet other criteria for reimbursement: major roadblocks to getting new therapies to patients.
Areas of Interest:
* Meaningful grants to senior level scientific and clinical investigators on the brink of new discoveries, working at the nation’s leading academic and research institutions, and in private industry.
* Seed funding for preliminary work necessary to explore novel approaches
* Building innovative platform technologies. Investigation of innovative tests to streamline the development of new therapies and the development of a genomics database for epilepsy.
* Research to bring new approaches and therapy to children
* Innovative cutting edge projects that could lead to breakthrough discoveries.
* Support for applying work in other areas which shows the potential for promise in epilepsy.
* Research programs that might not otherwise be funded through traditional sources.
* Projects that encourage collaboration among scientists and industry.
* Proposals dealing with commercializing academic research projects.
Disciplinary Category:
Medical - Translational.
Applicant Type:
Investigators must hold a relevant advanced degree (M.D.and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena. All applications will be judged on a competitive basis, without regard to the academic rank or title of the investigator. Applicants whose research will involve patient care or direct involvement with patients must be licensed to practice their profession at their institution and must obtain Institutional Review Board (IRB) approval of their research. IRB approval must be included with the original application.
Award Amount:
Awards will range between $100,000 to $200,000 per year. Multi-year awards will be considered.
Numerical value: $200,000
Application Process:
Application instructions and forms can be obtained at the foundation website.
Funding Agency Contact:
Epilepsy Foundation
Cassandra Richard, Research Coordinator
4351 Garden City Drive
Landover MD 20785-7223
Phone: 301/918-3724
Email: crichard@efa.org
Deadlines:
Mar. 1, 2010 (REQUIRED letter of intent); Apr. 23, 2010 (invited application).
* Seed funding for preliminary and targeted work deemed necessary to explore novel therapeutic approaches
* Projects which if successful offer a clear path to downstream development
* Proposals that support the commercialization of exceptional academic research projects
* Research to bring new approaches and therapy to children
Key issues for reviewers are whether the program could lead to a new therapy that is approvable by FDA or meet other criteria for reimbursement: major roadblocks to getting new therapies to patients.
Areas of Interest:
* Meaningful grants to senior level scientific and clinical investigators on the brink of new discoveries, working at the nation’s leading academic and research institutions, and in private industry.
* Seed funding for preliminary work necessary to explore novel approaches
* Building innovative platform technologies. Investigation of innovative tests to streamline the development of new therapies and the development of a genomics database for epilepsy.
* Research to bring new approaches and therapy to children
* Innovative cutting edge projects that could lead to breakthrough discoveries.
* Support for applying work in other areas which shows the potential for promise in epilepsy.
* Research programs that might not otherwise be funded through traditional sources.
* Projects that encourage collaboration among scientists and industry.
* Proposals dealing with commercializing academic research projects.
Disciplinary Category:
Medical - Translational.
Applicant Type:
Investigators must hold a relevant advanced degree (M.D.and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena. All applications will be judged on a competitive basis, without regard to the academic rank or title of the investigator. Applicants whose research will involve patient care or direct involvement with patients must be licensed to practice their profession at their institution and must obtain Institutional Review Board (IRB) approval of their research. IRB approval must be included with the original application.
Award Amount:
Awards will range between $100,000 to $200,000 per year. Multi-year awards will be considered.
Numerical value: $200,000
Application Process:
Application instructions and forms can be obtained at the foundation website.
Funding Agency Contact:
Epilepsy Foundation
Cassandra Richard, Research Coordinator
4351 Garden City Drive
Landover MD 20785-7223
Phone: 301/918-3724
Email: crichard@efa.org
Deadlines:
Mar. 1, 2010 (REQUIRED letter of intent); Apr. 23, 2010 (invited application).
Subscribe to Posts [Atom]